<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.994295</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Construction and validation of a robust prognostic model based on immune features in sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Yongxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1434342"/>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Baiyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Xiumei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1401086"/>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yubiao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yongbo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/428886"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1434482"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Yonghao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1416966"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sang</surname>
<given-names>Ling</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1129088"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xiaoqing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1268802"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Yimin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/999293"/>
</contrib>
</contrib-group>    <aff id="aff1">
<sup>1</sup>
<institution>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>    <aff id="aff2">
<sup>2</sup>
<institution>The First Affiliated Hospital, Guangzhou Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Borna Relja, Otto von Guericke University, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Na Cui, Peking Union Medical College Hospital (CAMS), China; Yi Yang, Southeast University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Yimin Li, <email xlink:href="mailto:dryiminli@vip.163.com">dryiminli@vip.163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>994295</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>07</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zheng, Liu, Deng, Chen, Huang, Zhang, Xu, Sang, Liu and Li</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zheng, Liu, Deng, Chen, Huang, Zhang, Xu, Sang, Liu and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Purpose</title>
<p>Sepsis, with life-threatening organ failure, is caused by the uncontrolled host response to infection. Immune response plays an important role in the pathophysiology of sepsis. Immune-related genes (IRGs) are promising novel biomarkers that have been used to construct the diagnostic and prognostic model. However, an IRG prognostic model used to predict the 28-day mortality in sepsis was still limited. Therefore, the study aimed to develop a prognostic model based on IRGs to identify patients with high risk and predict the 28-day mortality in sepsis. Then, we further explore the circulating immune cell and immunosuppression state in sepsis.</p>
</sec>
<sec>
<title>Materials and methods</title>
<p>The differentially expressed genes (DEGs), differentially expressed immune-related genes (DEIRGs), and differentially expressed transcription factors (DETFs) were obtained from the GEO, ImmPort, and Cistrome databases. Then, the TFs-DEIRGs regulatory network and prognostic prediction model were constructed by Cox regression analysis and Pearson correlation analysis. The external datasets also validated the reliability of the prognostic model. Based on the prognostic DEIRGs, we developed a nomogram and conducted an independent prognosis analysis to explore the relationship between DEIRGs in the prognostic model and clinical features in sepsis. Besides, we further evaluate the circulating immune cells state in sepsis.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of seven datasets were included in our study. Among them, GSE65682 was identified as a discovery cohort. The results of GSEA showed that there is a significant correlation between sepsis and immune response. Then, based on a P value &lt;0.01, 69 prognostic DEIRGs were obtained and the potential molecular mechanisms of DEIRGs were also clarified. According to multivariate Cox regression analysis, 22 DEIRGs were further identified to construct the prognostic model and identify patients with high risk. The Kaplan&#x2013;Meier survival analysis showed that high-risk groups have higher 28-day mortality than low-risk groups (P=1.105e-13). The AUC value was 0.879 which symbolized that the prognostic model had a better accuracy to predict the 28-day mortality. The external datasets also prove that the prognostic model had an excellent prediction value. Furthermore, the results of correlation analysis showed that patients with Mars1 might have higher risk scores than Mars2-4 (P=0.002). According to the previous study, Mars1 endotype was characterized by immunoparalysis. Thus, the sepsis patients in high-risk groups might exist the immunosuppression. Between the high-risk and low-risk groups, circulating immune cells types were significantly different, and risk score was significantly negatively correlated with naive CD4+ T cells (P=0.019), activated NK cells (P=0.0045), monocytes (P=0.0134), and M1 macrophages (P=0.0002).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Our study provides a robust prognostic model based on 22 DEIRGs which can predict 28-day mortality and immunosuppression status in sepsis. The higher risk score was positively associated with 28-day mortality and the development of immunosuppression. IRGs are a promising biomarker that might facilitate personalized treatments for sepsis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>sepsis</kwd>
<kwd>immune</kwd>
<kwd>prognostic model</kwd>
<kwd>28-day mortality</kwd>
<kwd>immunosuppression</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Natural Science Foundation of Guangdong Province<named-content content-type="fundref-id">10.13039/501100003453</named-content>
</contract-sponsor>
<contract-sponsor id="cn005">Natural Science Foundation of Guangdong Province<named-content content-type="fundref-id">10.13039/501100003453</named-content>
</contract-sponsor>
<contract-sponsor id="cn006">Guangzhou Municipal Science and Technology Project<named-content content-type="fundref-id">10.13039/501100010256</named-content>
</contract-sponsor>
<counts>
<fig-count count="11"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="17"/>
<word-count count="5930"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Sepsis is a complex disorder that develops as a severe systemic inflammatory response to infection, and is associated with high mortality (<xref ref-type="bibr" rid="B1">1</xref>). According to the US report, there were 48.9 (38.9-62.9) million incident cases of sepsis in the world annually and 11.0 (10&#xb7;1-12&#xb7;0) million patients died with sepsis (<xref ref-type="bibr" rid="B2">2</xref>). Sepsis was recognized as the most expensive burden and threat to human health. Increased mortality was associated with delay in initiating early treatments. The previous study estimated that the survival rate decreases by roughly 10% every hour that appropriate antimicrobial medication is delayed, emphasizing the urgent need for early identification and precise treatments to improve clinical outcomes (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). In 2017, World Health Organization (WHO) also declared that the improvement of sepsis early prevention, early recognition, and treatment is a global health priority (<xref ref-type="bibr" rid="B5">5</xref>). Therefore, the identification of septic patients at high risk may help clinicians to screen and identify individuals who are most likely to have poor prognosis, or to detect immunosuppressed states which could benefit from targeted immunostimulating therapies, and eventually improve patients&#x2019; prognosis.</p>
<p>Sepsis is an uncontrolled inflammatory response to invasive infection which can disturb homeostasis. After infection, the immune response can eliminate the pathogens but sometimes the host will release damage-associated molecular patterns (DAMPs) to damage organs. However, in late sepsis, sepsis patients have immune suppression which is characterized the lymphocyte exhaustion and the reprogramming of antigen&#x2212;presenting cells (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). In face of the complex pathophysiology of sepsis and its often challenging clinical evaluation, promising diagnostic biomarkers in sepsis are emerging with the application of blood genomics. Scicluna et&#xa0;al. (<xref ref-type="bibr" rid="B8">8</xref>) established endotypes for patients with sepsis through genome-wide blood gene expression profiles. The study provided a method to classify sepsis patients into four different endotypes and the detection of sepsis endotypes may assist in the precise treatments. Besides, increasing studies have identified novel immune biomarkers for early diagnosis and guide immunotherapies in oncology research. The immune related-genes (IRGs) model had been successfully applied in oncology to identify patients at high risk and estimate overall survival (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). However, a robust IRGs model to identify high-risk patients and predict prognosis for adult patients with all-cause sepsis is still lacking.</p>
<p>The primary objective of this study was to construct an IRGs model to predict the prognosis of adult patients with all-cause sepsis. To achieve this aim, we obtain the differentially expressed IRGs (DEIRGs) that we can establish the Cox prediction model based on DEIRGs to predict the patients at high risk and the prognosis for patients with sepsis. Then, we construct a regulatory network between differentially expressed transcription factors (DETFs) and DEIRGs to explore the underlying molecular mechanisms. Besides, we further analyze the immune microenvironment in sepsis patients. Finally, we tested the robustness of the predictive model across the other datasets, and we provided a quantitative tool for predicting the individual probability of death.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Datasets selection, data acquisition, and processing</title>
<p>A workflow is shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. The Gene Expression Omnibus (GEO) (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</uri>) and ArrayExpress (<uri xlink:href="https://www.ebi.ac.uk/arrayexpress/">https://www.ebi.ac.uk/arrayexpress/</uri>) databases were comprehensively searched from inception to April 2022 to obtain the relevant datasets. The inclusion criteria of datasets were: (1) diagnosis of patients with sepsis; (2) sample size more than 50; (3) age &#x2265;18 years; (4) the endpoints included 28-day mortality; (5) the patient&#x2019;s specimens were collected before 24h on ICU admission and anti-inflammation treatments. Therefore, the 7 datasets were included in the study. Among them, GSE65682 was recognized as a training set because it was a large cohort study, and the other datasets were retained for model validation. The details of these datasets are shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. To identify IRGs, we downloaded 2,483 IRGs from the Immunology Database and Analysis Portal (ImmPort) (<uri xlink:href="http://www.immport.org/">http://www.immport.org/</uri>). Moreover, to construct the regulatory network, we obtained the transcription factors (TFs) from Cistrome Project (<uri xlink:href="http://www.cistrome.org/">http://www.cistrome.org/</uri>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flowchart of data analysis and validation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g001.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Basic information of the datasets included in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Accession</th>
<th valign="top" align="center">Study population</th>
<th valign="top" align="center">Sample type</th>
<th valign="top" align="center">Country</th>
<th valign="top" align="center">Timing of gene expression profiling</th>
<th valign="top" align="center">Mortality / Total patients</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">GSE65682</td>
<td valign="top" align="left">Patient diagnoses sepsis due to cap, hap and non-infectious control.</td>
<td valign="top" align="left">Blood</td>
<td valign="top" align="left">Netherlands and England</td>
<td valign="top" align="left">On ICU admission</td>
<td valign="top" align="left">114 / 802</td>
</tr>
<tr>
<td valign="top" align="left">GSE63042</td>
<td valign="top" align="left">Patients with SIRS or sepsis</td>
<td valign="top" align="left">Blood</td>
<td valign="top" align="left">America</td>
<td valign="top" align="left">The day of enrollment upon presentation to the ED.</td>
<td valign="top" align="left">28 / 129</td>
</tr>
<tr>
<td valign="top" align="left">GSE95233</td>
<td valign="top" align="left">Patients with septic shock and healthy volunteers</td>
<td valign="top" align="left">Blood</td>
<td valign="top" align="left">France</td>
<td valign="top" align="left">Day 1 of ICU admission</td>
<td valign="top" align="left">34 / 124</td>
</tr>
<tr>
<td valign="top" align="left">GSE106878</td>
<td valign="top" align="left">septic shock patients from the CORTICUS-trial</td>
<td valign="top" align="left">Circulating leukocytes</td>
<td valign="top" align="left">International</td>
<td valign="top" align="left">Before hydrocortisone application</td>
<td valign="top" align="left">26 / 94</td>
</tr>
<tr>
<td valign="top" align="left">E-MTAB-4451</td>
<td valign="top" align="left">Patients with severe sepsis due to CAP</td>
<td valign="top" align="left">Circulating leukocytes</td>
<td valign="top" align="left">England</td>
<td valign="top" align="left">On ICU admission</td>
<td valign="top" align="left">52 / 106</td>
</tr>
<tr>
<td valign="top" align="left">E-MTAB-5273</td>
<td valign="top" align="left">Patients with sepsis due to CAP or faecal peritonitis.</td>
<td valign="top" align="left">Circulating leukocytes</td>
<td valign="top" align="left">England</td>
<td valign="top" align="left">First day of ICU stay</td>
<td valign="top" align="left">43 / 221</td>
</tr>
<tr>
<td valign="top" align="left">E-MTAB-5274</td>
<td valign="top" align="left">Patients with sepsis due to CAP or faecal peritonitis.</td>
<td valign="top" align="left">Circulating leukocytes</td>
<td valign="top" align="left">England</td>
<td valign="top" align="left">First day of ICU stay</td>
<td valign="top" align="left">14 / 106</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_2">
<title>Differential expression analysis in sepsis</title>
<p>All the genes in GSE65682 were differentially analyzed by using limma R packages (<uri xlink:href="http://www.bioconductor.org/packages/release/bioc/html/limma.html">http://www.bioconductor.org/packages/release/bioc/html/limma.html</uri>) (<xref ref-type="bibr" rid="B11">11</xref>). The parameter for DEGs screened was&#x2502;Log2Foldchange&#x2502;&#x2265;0.5 and P-value &lt; 0.05. The Volcano plots were drawn by &#x2018;ggplot2&#x2019; R package. Then, the IRGs that were overlapping with DEGs were identified as DEIRGs. Similarly, DETFs were obtained by matching TFs with DEGs.</p>
</sec>
<sec id="s2_3">
<title>DEGs and gene set enrichment analysis</title>
<p>GSEA was used to assess related pathways and molecular mechanisms in sepsis. We performed the GSEA by the R package &#x2018;clusterProfiler&#x2019;. Normalized enrichment score (NES) and false discovery rate (FDR) were used to quantify enrichment magnitude and statistical significance, respectively (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>).</p>
</sec>
<sec id="s2_4">
<title>Identification of prognostic DEIRGs and construction of the regulatory network</title>
<p>To identify the prognostic DEIRGs (P &lt;0.01), R package &#x2018;survival R&#x2019; was used to perform univariate Cox regression analysis. Then, it is important to further explore the mechanisms of TFs to regulate the prognostic DEIRGs. Thus, we further analyzed the coexpression relationship between TFs and prognostic DEIRGs by calculating Pearson&#x2019;s correlation coefficient. A regulatory network was constructed based on the filter thresholds (P value &lt;0.001 and |cor| &gt; 0.5). The network was visualized by using Cytoscape software.</p>
</sec>
<sec id="s2_5">
<title>Construction of the prognostic prediction model in sepsis and development of nomogram</title>
<p>Based on the univariate Cox regression analysis, prognostic DEIRGs were recognized as the biomarkers for multivariate Cox regression analysis. According to the median risk score value, conducted between low-risk and high-risk groups by using &#x2018;survival&#x2019; R package. To evaluate the sensitivity and specificity of the prediction model, the receiver operating characteristics (ROC) curve was calculated using the &#x2018;survivalROC&#x2019; package. The area under the ROC curve (AUC) was used to evaluate the prognostic model: 0.5-0.7 (moderate), 0.7-0.8 (better), and &gt;0.9 (excellent).</p>
<p>To provide a quantitative tool for predicting probability of 28-day mortality  in septic patients, we construct a nomogram according to the DEIRGs in the prognostic model and clinic features. The patients' clinic features are shown in <xref ref-type="supplementary-material" rid="ST1">
<bold>Supplementary Table 1</bold>
</xref>.</p>
</sec>
<sec id="s2_6">
<title>Validation in multiple external datasets</title>
<p>To evaluate the predictive performance of the prognostic model, 6 datasets (GSE63062, GSE95233, GSE106878, E-MTAB-4451, E-MTAB-5273, and E-MTAB-5274) were included according to the inclusion criteria. The prognostic model was used to predict the 28-day mortality of external datasets. Furthermore, the ROC curve was generated to determine sensitivity and specificity in the prognostic model.</p>
</sec>
<sec id="s2_7">
<title>Gene ontology and pathway enrichment analysis for DEIRGs in the prognostic model</title>
<p>To explore the mechanisms and functions of DEIRGs in the prognostic model, we performed Gene Ontology (GO) and Pathway Enrichment Analysis (KEGG) through the DAVID database (<uri xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</uri>). Upon GO analysis and KEGG analysis, a P value &lt;0.05 was recognized as statistical significance. The results of GO analysis were classified into three functional groups: biological process (BP), molecular function (MF), and cellular component (CC).</p>
</sec>
<sec id="s2_8">
<title>Correlation analysis between clinical features and DEIRGs in prognostic model</title>
<p>The correlation between risk score, gene expression value, and clinical features (age, gender, diabetes, ICU acquired infection (ICUA), and endotype class) were analyzed by using the &#x2018;beeswarm&#x2019; R package. A P value &lt;0.05 indicated statistical significance.</p>
</sec>
<sec id="s2_9">
<title>Exploration of circulating immune cells between low-risk and high-risk groups</title>
<p>CIBERSORTx (<uri xlink:href="https://cibersort.stanford.edu/">https://cibersort.stanford.edu/</uri>), an online analytical tool based on a kind of deconvolution algorithm iterated 1000 times, was available to provide an estimation of the abundances of member cell types in a mixed cell population by using gene expression data (<xref ref-type="bibr" rid="B14">14</xref>). Then, the content of 22 types of circulating immune cells in each sample was visualized by a vertical stack bar. Furthermore, the difference analysis of immune cells between low-risk and high-risk groups was shown by drawing barplot diagrams. Additionally, we explored the correlation between immune cells and risk score by Spearman correlation analyses. A P value &lt;0.05 was considered statistical significance.</p>
</sec>
<sec id="s2_10">
<title>Statistical analysis</title>
<p>All statistical analyses were performed using R software and Grapad prism 9.0. The &#x2018;limma R&#x2019; package was used to conduct differential expression analysis. The R package &#x2018;clusterProfiler&#x2019; was adopted for assessing related pathways and molecular mechanisms in sepsis. The prognostic prediction model was constructed by univariate and multivariate Cox regression analysis. Besides, the &#x2018;survival&#x2019;, &#x2018;survival ROC&#x2019;, and &#x2018;risk Plot&#x2019; R packages were applied to evaluate the survival difference between the high-risk and low-risk groups and assess the sensitivity and specificity in the prognostic model. Then, the &#x2018;beeswarm&#x2019; R package was used to explore the correlation between clinical features and DEIRGs in the prognostic model. P value &lt; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>DEGs, DEIRGs, DETFs and GSEA analysis</title>
<p>After the differential expression analysis of GSE65682, we obtained 3,648 DEGs (FDR &lt;0.05, &#x2502;Log2FC&#x2502;&#x2265;0.5) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>; <xref ref-type="supplementary-material" rid="ST2">
<bold>Supplementary Table 2</bold>
</xref>). To identify the DEIRGs, we downloaded all 2,483 immune genes from the ImmPORT database. Then, we matched IRGs with DEGs and obtained 278 DEIRGs (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B, D</bold>
</xref>; <xref ref-type="supplementary-material" rid="ST3">
<bold>Supplementary Table 3</bold>
</xref>). Similarly, we searched and downloaded all 1,560 TFs from the Cistrome database. We matched TFs with DEGs and obtained 348 DETFs (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C, E</bold>
</xref>; <xref ref-type="supplementary-material" rid="ST4">
<bold>Supplementary Table 4</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Screening DEGs, DEIRGs and DETFs. <bold>(A)</bold> Volcano plot showing DEGs in GSE66890; <bold>(B)</bold> Venn diagram showed DEIRGs; <bold>(C)</bold> Venn diagram showed DETFs; <bold>(D)</bold> Volcano plot showing DEIRGs; <bold>(E)</bold> Volcano plot showing DETFs. Based on the |fold change|&gt;0.5 and FDR&lt;0.05, the red points represent upregulated genes and the green points represent downregulated genes. No significant differences are showed in black.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g002.tif"/>
</fig>
<p>In order to explore the immune response in sepsis, we downloaded the KEGG gene sets and all GO gene sets from MsigDB. Then, the changes of these pathways and functions in gene sets were analyzed, namely Healthy vs Sepsis. According to our analysis, we found that immune response played an important role in the development of sepsis. In GO gene sets, we found that adaptive immune response was significantly upregulated in sepsis. However, cell activation involved in immune response, immune effector process, and myeloid leukocyte activation were upregulated in healthy and sepsis (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). In KEGG gene sets, antigen processing and presentation, natural killer cell-mediated cytotoxicity, and primary immunodeficiency were most significantly increased (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>). Our results showed that there is a significant correlation between sepsis and immune response, and provide a theoretical basis for the construction of immune genes model to predict the prognosis of sepsis patients.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Exploring the difference of immune response between sepsis and healthy by using GSEA. <bold>(A)</bold> The enriched gene sets in GO collection; <bold>(B)</bold> The results of GO analysis from GSEA; <bold>(C)</bold> The enriched gene sets in KEGG collection; <bold>(D)</bold> The results of KEGG analysis from GSEA. The enrichment score of curve above 0 points indicates that the gene sets were activated in healthy. The curve below 0 points indicates that the gene sets were activated in sepsis. p.adjust, adjusted p-value; NES, normalized enrichment score.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g003.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Identification of prognostic DEIRGs and construction of regulatory network</title>
<p>Univariate Cox regression analysis was applied to screen and identify the prognostic genes in sepsis. According to P value &lt;0.01, 69 prognostic DEIRGs were obtained (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>; <xref ref-type="supplementary-material" rid="ST5">
<bold>Supplementary Table 5</bold>
</xref>). Among them, 11 prognostic DEIRGs were high-risk and the others were low-risk. Then, to explore the molecular mechanisms between DETFs and prognostic DEIRGs, a regulatory network between DETFs and prognostic DEIRGs was constructed (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>; <xref ref-type="supplementary-material" rid="ST6">
<bold>Supplementary Table 6</bold>
</xref>). A total of 69 prognostic DEIRGs and 10 TFs were shown in the regulatory network (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). As shown in the regulatory network, almost all expression level of high-risk DEIRGs (MPO, PTX3, DEFA4, CTSG, AZU1, ELANE, and RNASE3) were upregulated by CEBPE. Additionally, IL1R2 was upregulated by BCL11B, and FURIN was regulated by KLF1, TFDP1, and MX11. Besides, most low-risk DEIRGs had a positive relationship with BCL11B, MYC, POLB, STAT1, RUNX2, and KLF10. The other low-risk DEIRGs (HCK, IL17RA, ISG20L2, and ITGAL) were negatively regulated by KLF1, TFDP1, and MX11. The coefficient filter &gt;0.5 and the P value &lt;0.001 were set as the threshold to indicate statistical significance.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Prognostic DEIRGs and regulatory network between DETFs and prognostic DEIRGs. <bold>(A)</bold> Forest plot for prognostic DEIRGs in sepsis. Red and green dots were recognized as high-risk and low-risk, respectively; <bold>(B)</bold> Regulatory network between prognostic DEIRGs and DETFs. The red and green circles indicate high-risk DEIRGs and low-risk DEIRGs, respectively. The yellow triangles were applied to symbolize the DETFs. Moreover, the red and green lines were used to indicate a positive and negative correlation between prognostic DEIRGs and DETFs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g004.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Construction of prognostic prediction model in sepsis</title>
<p>The 69 prognostic DEIRGs were obtained by univariate Cox regression analysis. Then, these prognostic DEIRGs were further incorporated into multivariate Cox regression analysis. Finally, 22 DEIRGs might serve to be the prognostic factors to independently predict the prognosis of sepsis patients (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Thus, the expression profiles of 22 DEIRGs were applied to construct the prognostic model to predict the 28-day mortality in sepsis patients. To obtain the survival risk score, the expression value and relative coefficients of 22 DEIRGs were used to calculate. The formulas was shown in <xref ref-type="supplementary-material" rid="ST7">
<bold>Supplementary Table 7</bold>
</xref>. Based on the median risk score value, 479 septic patients  were classified into a high-risk group (n= 239) and a low-risk group (n=240) (<xref ref-type="supplementary-material" rid="ST7">
<bold>Supplementary Table 7</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Multivariate Cox regression analyses of 22 IRGs of risk model in sepsis.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">DEIRGs</th>
<th valign="top" align="center">coef</th>
<th valign="top" align="center">HR</th>
<th valign="top" align="center">HR.95L</th>
<th valign="top" align="center">HR.95H</th>
<th valign="top" align="center">pvalue</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">ADRB2</td>
<td valign="top" align="left">-0.693479</td>
<td valign="top" align="left">0.499834</td>
<td valign="top" align="left">0.3647514</td>
<td valign="top" align="left">0.6849434</td>
<td valign="top" align="left">1.60E-05</td>
</tr>
<tr>
<td valign="top" align="left">CD1D</td>
<td valign="top" align="left">-0.394755</td>
<td valign="top" align="left">0.6738449</td>
<td valign="top" align="left">0.4833991</td>
<td valign="top" align="left">0.9393211</td>
<td valign="top" align="left">0.0198413</td>
</tr>
<tr>
<td valign="top" align="left">CD74</td>
<td valign="top" align="left">0.7029737</td>
<td valign="top" align="left">2.0197499</td>
<td valign="top" align="left">1.102899</td>
<td valign="top" align="left">3.6987881</td>
<td valign="top" align="left">0.0227718</td>
</tr>
<tr>
<td valign="top" align="left">CETP</td>
<td valign="top" align="left">-1.176492</td>
<td valign="top" align="left">0.3083585</td>
<td valign="top" align="left">0.2045131</td>
<td valign="top" align="left">0.4649334</td>
<td valign="top" align="left">1.96E-08</td>
</tr>
<tr>
<td valign="top" align="left">ELANE</td>
<td valign="top" align="left">0.3804079</td>
<td valign="top" align="left">1.4628811</td>
<td valign="top" align="left">0.9891965</td>
<td valign="top" align="left">2.1633934</td>
<td valign="top" align="left">0.0567083</td>
</tr>
<tr>
<td valign="top" align="left">FYN</td>
<td valign="top" align="left">0.4151731</td>
<td valign="top" align="left">1.5146329</td>
<td valign="top" align="left">0.9758725</td>
<td valign="top" align="left">2.3508326</td>
<td valign="top" align="left">0.0641593</td>
</tr>
<tr>
<td valign="top" align="left">GNLY</td>
<td valign="top" align="left">-0.244232</td>
<td valign="top" align="left">0.7833063</td>
<td valign="top" align="left">0.6309512</td>
<td valign="top" align="left">0.9724504</td>
<td valign="top" align="left">0.0268901</td>
</tr>
<tr>
<td valign="top" align="left">HLA-DRA</td>
<td valign="top" align="left">-0.761003</td>
<td valign="top" align="left">0.4671977</td>
<td valign="top" align="left">0.2847489</td>
<td valign="top" align="left">0.7665478</td>
<td valign="top" align="left">0.0025925</td>
</tr>
<tr>
<td valign="top" align="left">IL16</td>
<td valign="top" align="left">1.0580916</td>
<td valign="top" align="left">2.8808678</td>
<td valign="top" align="left">1.2936444</td>
<td valign="top" align="left">6.4155183</td>
<td valign="top" align="left">0.0095908</td>
</tr>
<tr>
<td valign="top" align="left">IL17RA</td>
<td valign="top" align="left">-0.54816</td>
<td valign="top" align="left">0.5780126</td>
<td valign="top" align="left">0.3256761</td>
<td valign="top" align="left">1.0258613</td>
<td valign="top" align="left">0.0611051</td>
</tr>
<tr>
<td valign="top" align="left">IL1R2</td>
<td valign="top" align="left">0.2860863</td>
<td valign="top" align="left">1.3312073</td>
<td valign="top" align="left">1.0111484</td>
<td valign="top" align="left">1.7525746</td>
<td valign="top" align="left">0.0414519</td>
</tr>
<tr>
<td valign="top" align="left">LTB</td>
<td valign="top" align="left">-0.651796</td>
<td valign="top" align="left">0.5211092</td>
<td valign="top" align="left">0.3413782</td>
<td valign="top" align="left">0.7954661</td>
<td valign="top" align="left">0.0025252</td>
</tr>
<tr>
<td valign="top" align="left">MPO</td>
<td valign="top" align="left">-0.615383</td>
<td valign="top" align="left">0.540434</td>
<td valign="top" align="left">0.3689694</td>
<td valign="top" align="left">0.7915804</td>
<td valign="top" align="left">0.0015765</td>
</tr>
<tr>
<td valign="top" align="left">PLXNC1</td>
<td valign="top" align="left">-0.488971</td>
<td valign="top" align="left">0.613257</td>
<td valign="top" align="left">0.3999037</td>
<td valign="top" align="left">0.9404368</td>
<td valign="top" align="left">0.0249953</td>
</tr>
<tr>
<td valign="top" align="left">PSME1</td>
<td valign="top" align="left">0.7359292</td>
<td valign="top" align="left">2.0874208</td>
<td valign="top" align="left">0.9682696</td>
<td valign="top" align="left">4.500116</td>
<td valign="top" align="left">0.0604232</td>
</tr>
<tr>
<td valign="top" align="left">TAP2</td>
<td valign="top" align="left">-0.386602</td>
<td valign="top" align="left">0.6793615</td>
<td valign="top" align="left">0.453822</td>
<td valign="top" align="left">1.0169892</td>
<td valign="top" align="left">0.0603643</td>
</tr>
<tr>
<td valign="top" align="left">TFRC</td>
<td valign="top" align="left">0.1729455</td>
<td valign="top" align="left">1.1888014</td>
<td valign="top" align="left">0.9450299</td>
<td valign="top" align="left">1.4954539</td>
<td valign="top" align="left">0.1396536</td>
</tr>
<tr>
<td valign="top" align="left">THBS1</td>
<td valign="top" align="left">0.3465734</td>
<td valign="top" align="left">1.4142134</td>
<td valign="top" align="left">1.1220993</td>
<td valign="top" align="left">1.782373</td>
<td valign="top" align="left">0.0033265</td>
</tr>
<tr>
<td valign="top" align="left">TNFRSF10B</td>
<td valign="top" align="left">0.7411038</td>
<td valign="top" align="left">2.0982502</td>
<td valign="top" align="left">1.4481151</td>
<td valign="top" align="left">3.0402651</td>
<td valign="top" align="left">8.97E-05</td>
</tr>
<tr>
<td valign="top" align="left">TNFSF12</td>
<td valign="top" align="left">-0.898271</td>
<td valign="top" align="left">0.4072731</td>
<td valign="top" align="left">0.230409</td>
<td valign="top" align="left">0.7198997</td>
<td valign="top" align="left">0.0019965</td>
</tr>
<tr>
<td valign="top" align="left">TRBV9</td>
<td valign="top" align="left">-0.336649</td>
<td valign="top" align="left">0.7141593</td>
<td valign="top" align="left">0.4942263</td>
<td valign="top" align="left">1.0319634</td>
<td valign="top" align="left">0.0730621</td>
</tr>
<tr>
<td valign="top" align="left">DEFA4</td>
<td valign="top" align="left">0.1906303</td>
<td valign="top" align="left">1.210012</td>
<td valign="top" align="left">0.9676379</td>
<td valign="top" align="left">1.513096</td>
<td valign="top" align="left">0.0946212</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Then, Kaplan&#x2013;Meier survival analysis was performed to analyze the 28-day mortality of high-risk groups (n= 239) and low-risk groups (n=240). As expected, the 28-day mortality of high-risk groups was significantly higher than low-risk group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>; <xref ref-type="supplementary-material" rid="ST8">
<bold>Supplementary Table 8</bold>
</xref>). Furthermore, we drew an ROC curve to evaluate the sensitivity and specificity of the prognostic model. The results showed that the AUC value was 0.879 which symbolized that the prognostic model had a better accuracy to predict the 28-day mortality of high-risk and low-risk groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Additionally, the riskscope curve was constructed (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>) and the survival status of the two groups is shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>. The differential expression analysis of 22 DEIRGs are shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Construction of prognostic model based on 22 DEGs. <bold>(A)</bold> Kaplan&#x2013;Meier survival analysis of 28-day mortality between high-risk groups (red) and low-risk groups (blue). The color of each survival line indicated the 95% CI of probability of survival at each time point. <bold>(B)</bold> The ROC curve showed the AUC value of prognostic model. <bold>(C)</bold> The risk score analysis between high-risk and low-risk groups. <bold>(D)</bold> The survival status analysis between high-risk and low-risk groups. <bold>(E)</bold> The differentially expression analysis of 22 DEIRGs in prognostic model from 479 sepsis patients.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g005.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Validation of prognostic model by external datasets</title>
<p>To further evaluate the accuracy and reliability of the prognostic model, six datasets in line with the inclusion criteria were chosen to perform external validation. ROC analysis was performed to investigate the prognostic value of the prediction model. The AUC was 0.805 in E-MTAB-4451 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>), AUC was 0.783 in E-MTAB-5273 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>), AUC was 0.913 in E-MTAB-5274 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>), AUC was 0.917 in GSE95233 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>), AUC was 0.796 in GSE106878 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>) and AUC was 0.915 in GSE63042 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6F</bold>
</xref>), respectively. Therefore, the IRGs prognostic model had an excellent prediction value.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>The prognostic efficacy of IRGs prognostic model. <bold>(A)</bold> The ROC curve of E-MTAB-4451 dataset. <bold>(B)</bold> The ROC curve of E-MTAB-5273 dataset. <bold>(C)</bold> The ROC curve of E-MTAB-5274 dataset. <bold>(D)</bold> The ROC curve of GSE95233 dataset. <bold>(E)</bold> The ROC curve of GSE106878 dataset. <bold>(F)</bold> The ROC curve of GSE63042 dataset.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g006.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Independent prognosis analysis and exploring the relationships between DEIRGs in prognostic model and clinical features in sepsis</title>
<p>The 22 DEIRGs in the prognostic model had a better predictive ability to investigate the 28-day mortality in sepsis. Then, we further conducted the univariate independent prognostic analysis and multivariate independent prognostic analysis to explore the correlation between clinical features and 28-day mortality in sepsis. The results of the univariate independent prognostic analysis showed that age (P = 0.019) and risk score (P &lt;0.001) were related to the 28-day mortality, respectively (<xref ref-type="supplementary-material" rid="ST9">
<bold>Supplementary Table 9</bold>
</xref>; <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). The results of the multivariate independent prognostic analysis also showed that age (P = 0.005) and risk score (P &lt;0.001) were the independent prognostic factors to predict the 28-day mortality in sepsis (<xref ref-type="supplementary-material" rid="ST10">
<bold>Supplementary Table 10</bold>
</xref>; <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>The results of univariate independent prognostic analysis and multivariate independent prognostic analysis. <bold>(A)</bold> Univariate independent prognostic analysis. <bold>(B)</bold> Multivariate independent prognostic analysis. The red dots and green dots in the forest map indicated that the clinical feature was a high-risk factor and low-risk factor, respectively. ICUA, ICU acquired infection.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g007.tif"/>
</fig>
<p>Then, the correlation between clinical features and DEIRGs in the prognostic model was further explored (<xref ref-type="supplementary-material" rid="ST11">
<bold>Supplementary Material 11</bold>
</xref>). Among the clinical features, the endotype class was classified into four classes, including Mars1, Mars2, Mars3, and Mars4 (<xref ref-type="bibr" rid="B8">8</xref>). According to the research, the Mars1 endotype was characterized by a pronounced decrease in the expression of genes corresponding to key innate and adaptive immune cell functions such as Toll-like receptor, nuclear factor &#x3ba;B (NF&#x3ba;B1) signaling, antigen presentation, and T-cell receptor signaling, which might be characterized by immune paralysis. The other endotypes (Mars2-4) were characterized by high expression of genes involved in pro-inflammatory (eg, NF-&#x3ba;B signaling) and innate (eg, interferon signaling) immune reactions, which are characterized as pro-inflammatory and innate immune response. As shown in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>, the expression level of CD1D was higher in ICU-acquired infection (ICUA). Besides, the expression levels of ADRB2, CD1D, CD74, FYN, GNLY, IL16, IL17RA, PLXNC1, PSME1, TAP2, TNFRSF10B and TNFSF12 in Mars2-4 were significantly higher than Mars1. The expression levels of DEFA4, ELANE, MPO, and TFRC were significantly lower in Mars1 compared to those in Mars2-4. Therefore, DEFA4, ELANE, MPO, and TFRC might be related to immune paralysis in sepsis. Additionally, patients with Mars1 might have higher risk scores than Mars2-4 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8R</bold>
</xref>) which was consistent with the results of Scicluna et&#xa0;al. (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Relationships between clinical features and DEIRGs in prognostic model. <bold>(A)</bold> Different expression of CD1D between the ICUA/NICUA in sepsis. <bold>(B&#x2013;R)</bold> Different expression of DEIRGs in prognostic model between Mars1 and Mars2-4 in sepsis. ICUA, ICU acquired infection; NICUA, No ICU acquired infection; Mars, molecular diagnosis and risk stratification of sepsis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g008.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Development of nomogram to predict the 28-day mortality in sepsis</title>
<p>We constructed a nomogram to predict the 28-day mortality in sepsis according to clinical features and DEIRGs in the prognostic model (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref>). The value of each of the variables was given a score based on the points scale axis. The total score was calculated by adding each single score. Then, the total points were projected to the 28-day mortality probability scale axis to estimate the probability of death in sepsis.</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>A constructed nomogram for 28-day mortality prediction of a patients with sepsis. ICUA, ICU acquired infection; Mars, molecular diagnosis and risk stratification of sepsis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g009.tif"/>
</fig>
</sec>
<sec id="s3_7">
<title>Functional analysis for DEIRGs in prognostic model</title>
<p>To explore the functional changes for DEIRGs in the prognostic model, we performed the functional enrichment analysis. The GO terms were divided into three functional groups, including biological process (BP), cell component (CC), and molecular function (MF). The top 10 significant enrichment results are shown in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>. In BP groups, DEIRGs were mainly enriched in antigen processing and presentation, positive regulation of cytokine production and positive regulation of leukocyte cell&#x2212;cell adhesion (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>). In CC groups, DEIRGs were mainly involved in MHC class II protein complex, MHC protein complex and phagocytic vesicle (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10B</bold>
</xref>). In MF groups, DEIRGs mainly enriched in cytokine binding, cytokine receptor activity and immune receptor activity (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10C</bold>
</xref>). As for the KEGG analysis, DEIRGs were mainly involved in antigen processing and presentation, cytokine&#x2212;cytokine receptor interaction and hematopoietic cell lineage (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10D</bold>
</xref>).</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>The functional enrichment analysis for DEIRGs in prognostic model. <bold>(A)</bold> Biological process. <bold>(B)</bold> Cell component. <bold>(C)</bold> Molecular function. <bold>(D)</bold> KEGG pathway enrichment analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g010.tif"/>
</fig>
</sec>
<sec id="s3_8">
<title>Correlation analysis between DEIRGs and circulating immune cells</title>
<p>Numerous studies had demonstrated that circulating immune cells levels were associated with the prognosis of patients (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Therefore, we wanted to explore the different status of circulating immune cells between low-risk and high-risk groups. As shown in <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure 1</bold>
</xref>, the status of immune cells was significantly different in low-risk groups compared to the high-risk groups. Then, we further analyzed the composition of immune cells between low-risk and high-risk groups. The results of CIBERSORTx demonstrated that compared to the high-risk groups, CD8+ T cells (P=0.0135), resting (P=0.0005), and activated NK cells (P&lt;0.0001), monocytes (P&lt;0.0001), and M1 macrophages (P&lt;0.0001) were more abundant in low-risk groups, while naive CD4+ T cells (P=0.0257), follicular helper T cells (P=0.0489) and activated dendritic cells (P&lt;0.0001) were significantly enriched in high-risk groups (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11A</bold>
</xref>). Besides, we also analyzed the correlation of risk score and 22 immune cell types <italic>via</italic> Spearman correlation analyses. The results showed that risk scores were significantly positively correlated with follicular helper T cells (P=0.0437), gamma delta T cells (P=0.0004), resting NK cells (P=0.0259), activated dendritic cells (P&lt;0.0001), and activated mast cells (P&lt;0.0001), whereas were significantly negatively correlated with naive CD4+ T cells (P=0.019), activated NK cells (P=0.0045), monocytes (P=0.0134) and M1 macrophages (P=0.0002).</p>
<fig id="f11" position="float">
<label>Figure&#xa0;11</label>
<caption>
<p>Comparison and correlation of circulating immune cells between low-risk and high-risk groups. <bold>(A)</bold> Comparison of circulating immune cells between low-risk and high-risk groups <italic>via</italic> CIBERSORTx. <bold>(B&#x2013;J)</bold> Correlation between risk scores and circulating immune cells <italic>via</italic> Spearman correlation analysis.  *p &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-994295-g011.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Sepsis, with high heterogeneity, is characterized by aberrant immune responses, including hyperinflammation and immune suppression (<xref ref-type="bibr" rid="B17">17</xref>). Increasingly, studies have pointed out that IRGs are promising novel biomarkers that may have important predictive and prognostic value (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Thus, our research demonstrates that immune response played an important role in the development of sepsis. Then, the Cox prediction model obtained the 22 DEIRGs to classify the patients into low-risk and high-risk groups and construct the prognostic model. The regulatory network between TFs and prognostic DEIRGs was constructed to reveal the potential novel molecular mechanisms in sepsis. In this study, the prognostic model had a better accuracy to predict the 28-day mortality in sepsis. The external datasets also validated that the prognostic model had an excellent prediction value. Besides, we further developed a nomogram to provide a tool for predicting the probability of 28-day mortality in sepsis. We further explore the functional changes <italic>via</italic> functional enrichment analysis. Finally, the circulating immune cells were evaluated by CIBERSORTx.</p>
<p>As we know, the biomarkers to diagnose and predict the prognosis of sepsis were lacking due to the complex pathogenesis and high heterogeneity in sepsis. The unbalanced immune response of sepsis was initially activated to release tremendous damage-associated molecular patterns (DAMPs) such as cytokines. The cytokine storm will further lead to organ damage and even death (<xref ref-type="bibr" rid="B20">20</xref>). However, longitudinal analyses of immune response showed that patients developed persistent inflammation and immunosuppression in the late stage of sepsis (<xref ref-type="bibr" rid="B21">21</xref>). Therefore, the aberrant immune responses during sepsis might reflect the disease progression. The results of GSEA in this study also showed that immune responses were significantly related to the development of sepsis (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<p>IRGs, promising novel biomarkers, had been used to predict the prognosis in many diseases (<xref ref-type="bibr" rid="B22">22</xref>). Even in sepsis, Lu et&#xa0;al. demonstrated the immune genes exhibited superior diagnostic and predictive efficacy in mortality than clinical characteristics (<xref ref-type="bibr" rid="B18">18</xref>). However, the molecular mechanisms of prognostic DEIRGs in sepsis were still unclear. In our study, we have identified 11 prognostic DEIRGs with high risk and 58 prognostic DEIRGs with low risk <italic>via</italic> univariate Cox regression analysis (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). TFs, as an enhancer or promoter, could regulate the genes&#x2019; expression by binding to a particular DNA region. The regulatory network was constructed between TFs and prognostic DEIRGs (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). We found key TFs (CEBPE, BCL11B, MYC, POLB, and STAT1) which had the most downstream DEIRGs and relatively high correlation coefficients. CEBPE has been demonstrated to be involved in the generation and proliferation of neutrophils (<xref ref-type="bibr" rid="B23">23</xref>). Besides, CEBPE was an important target to promote the innate immune system (e.g. neutrophil) to kill the bacteria (<xref ref-type="bibr" rid="B24">24</xref>). In this study, almost high-risk DEIRGs (MPO, PTX3, DEFA4, CTSG, AZU1, ELANE, and RNASE3) were upregulated by CEBPE which indicated that these high-risk DEIRGs might promote the inflammation and innate immune responses. Additionally, the BCL11B gene was essential for T cell and NK cell development and function (<xref ref-type="bibr" rid="B25">25</xref>). MYC, POLB, and STAT1 have also been described as having a strong relationship to the functions of the immune system and the clearance of pathogens (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>). Therefore, most low-risk DEIRGs had a positive relationship with BCL11B, MYC, POLB and STAT1 might have an important role in regulating immune responses and defending against pathogens.</p>
<p>To construct the prognostic model, we further conducted the multivariate Cox regression analysis to identify the prognostic DEIRGs (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Then, the prognostic model could predict the 28-day mortality in sepsis with better accuracy (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5B</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref>). Among them, we obtained 4 high-risk genes (ELANE, IL1R2, MPO, and DEFA4) and 18 low-risk genes. ELANE and MPO had been demonstrated to involve in neutrophil protease activity. The expression levels of ELANE and MPO were correlated directly with organ failure and mortality which was in line with our results (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Besides, IL1R2, a decoy receptor for IL-1, has been implicated in sepsis (<xref ref-type="bibr" rid="B31">31</xref>). Previous studies have proven that IL1R2 was a biomarker to distinguish septic shock from non-septic shock postsurgical patients. The high expression of IL1R2 was significantly correlated to death in patients with postsurgical shock (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Interestingly, Liang et&#xa0;al. (<xref ref-type="bibr" rid="B34">34</xref>) pointed out that IL1R2 could distinguish gram-negative/gram-positive bacterial infection. The elevation of serum IL1R2 could be a biomarker to diagnose septic patients infected by gram-negative bacteria.</p>
<p>As we know, numerous studies have provided prognostic models/biomarkers for predicting overall survival in sepsis. However, these predictive factors were not applied to all sepsis patients due to the high heterogeneity. Thus, it is critical to stratify patients to guide treatments. A VANISH randomized trial categorized patients into SRS (sepsis response signatures) 1 and SRS2 according to transcriptomic profile. Patients with the immunocompetent SRS2 endotype might have significantly higher mortality when treated with corticosteroids than with placebo (<xref ref-type="bibr" rid="B35">35</xref>). Additionally, Scicluna et&#xa0;al. (<xref ref-type="bibr" rid="B8">8</xref>) classified patients with sepsis into four different endotypes (Mars1, Mars2, Mars3 and Mars4) upon ICU admission. According to the research, Mars1, with TAP2 transcripts denoting, was characterized by immune paralysis and poor prognosis, whereas Mars2-4 were characterized by high expression of pro-inflammatory genes. Our research also demonstrated that TAP2 was significantly downregulated in Mars1 compared to Mars2-4 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8N</bold>
</xref>). TAP2 was a subunit of major histocompatibility complex class I (MHC-I) molecules involved in antigen processing (<xref ref-type="bibr" rid="B36">36</xref>). TAP2 has the potential to inhibit lipopolysaccharide-induced proinflammation by negative regulation of toll-like receptor-4 (TLR4) (<xref ref-type="bibr" rid="B37">37</xref>). Besides, our research also showed that most sepsis patients with high risk might have the Mars1 endotype which indicated the poor prognosis of patients with the Mars1 endotype (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8R</bold>
</xref>). This result was also in line with the previous study. Therefore, patients with sepsis in immunosuppression might be associated with an increased risk of mortality.</p>
<p>As we know, patients who survive early sepsis often develop a hypoinflammatory state and nosocomial infections which lead to high mortality (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Immune suppression in patients with sepsis is characterized by enhanced apoptosis of immune cells, T cell exhaustion, and reduced expression of activating cell surface molecules. Previous studies have proven that T cell exhaustion in immunosuppression was related to poor outcomes (<xref ref-type="bibr" rid="B38">38</xref>). The apoptosis of T cells (CD4+, CD8+, and Th17) will result in immunosuppression and is associated with higher mortality (<xref ref-type="bibr" rid="B39">39</xref>). Besides, nature killer (NK) cells could clear the pathogens and promote inflammation through the production of IFN-&#x3b3;. However, NK cells will become tolerant and cytokine production of IFN-&#x3b3; and TNF-&#x3b1; will be impaired in the late stage of sepsis. The proportion of NK cells in lymphocytes was negatively associated with 28-day mortality in septic patients (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Monocytes and macrophages are important components of the immune system that can remove pathogens and contribute to the immune response by antigen presentation. The M1 macrophages were characterized by the production of proinflammatory cytokines and antimicrobial activity. However, the polarization of M1 macrophages will be inhibited in immunosuppression. The M1 macrophage reprogramming will develop a pathological anti-inflammatory response to sepsis and increase the risk of immunosuppression (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). In our research, CD8+ T cells (P=0.0135), resting (P=0.0005) and activated NK cells (P&lt;0.0001), monocytes (P&lt;0.0001), and M1 macrophages (P&lt;0.0001) were more abundant in low-risk groups which indicated a hyperinflammatory state in low-risk groups (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11A</bold>
</xref>). Besides, the results of correlation analyses also showed that risk scores were significantly negatively correlated with naive CD4+ T cells (P=0.019), activated NK cells (P=0.0045), monocytes (P=0.0134), and M1 macrophages (P=0.0002) (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11</bold>
</xref>). In toto, the patients with high risk scores might be associated with immunosuppression. The risk score was positively associated with the development of immunosuppression in sepsis. The risk score might provide assistance for distinguishing sepsis patients with immunosuppression.</p>
<p>However, in spite of the remarkable results, there are several limitations that we could not ignore. First, a lot of publicly available sepsis datasets were excluded for lacking the mortality outcome. These datasets might concentrate on the differential diagnosis or other poor outcomes. The exclusion of these datasets might cause potential selection bias. Second, our prognostic model had a better performance in distinguishing patients with high risk, evaluating 28-day mortality in sepsis, and identifying sepsis patients with immunosuppression. However, it still needs large prospective cohorts to validate the performance before the prognostic model was applied to general use. Third, the datasets we included did not provide the details of comorbidities or other diseases. Therefore, we can&#x2019;t exclude the impact of these factors on the prognostic model. Fourth, it may not accurately identify the immune cell types in sepsis according to bulk RNA-Seq data and the CIBERSORTx deconvolution algorithm. It still required further experiments (e.g. Flow Cytometry) to validate the results. Finally, the <italic>vivo</italic> and <italic>vitro</italic> experiments may help us identify the hub genes to predict the prognosis of sepsis and identify the patients with immunosuppression.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>Our study demonstrated that immune response played an important role in the development of sepsis. IRGs, as promising novel biomarkers, were used to construct the TFs-DEIRGs regulatory network and prognostic prediction model, respectively. The TF-DEIRGs regulatory network has revealed the potential molecular mechanisms for DEIRGs in sepsis. The prognostic model, with great performance, could identify the patients with high risk and predict the 28-day mortality in patients with sepsis. Besides, the prognostic DEIRGs were also related to the immune cell circulating and immunosuppression state, which might promote individualized therapy for sepsis patients.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Material</bold>
</xref>.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>YoZ and YH analysed and interpreted the data. YoZ, YuZ, YC and BL performed the bioinformatics analyses. XD, YX and LS performed data acquisition and figure preparations. YoZ and YH wrote the manuscript. XL and YL revised and edited this paper. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (81870069, 81970071, 82070084, 82270085), the Natural Science Foundation of Guangdong Province (2020A1515011459, 2021A1515012565), the Science and Technology Program of Guangzhou (202102010366, 202201020444), the State Key Laboratory of Respiratory Disease Independent Program (SKLRD-Z-202108), Guangdong Marine Economy Development Special Project (GDNRC[2022]35).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.994295/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2022.994295/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table_1.csv" id="ST1" mimetype="text/csv">
<label>Supplementary Table&#xa0;1</label>
<caption>
<p>The clinic features of GSE65682.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_2.csv" id="ST2" mimetype="text/csv">
<label>Supplementary Table&#xa0;2</label>
<caption>
<p>The differential expression analysis of GSE65682.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_3.csv" id="ST3" mimetype="text/csv">
<label>Supplementary Table&#xa0;3</label>
<caption>
<p>The differential expression analysis of IRGs.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_4.csv" id="ST4" mimetype="text/csv">
<label>Supplementary Table&#xa0;4</label>
<caption>
<p>The differential expression analysis of TFs.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_1.tif" id="SF1" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>The status of circulating immune cells between low-risk and high-risk groups.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_5.docx" id="ST5" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_6.docx" id="ST6" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_7.docx" id="ST7" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_8.docx" id="ST8" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_9.docx" id="ST9" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_10.docx" id="ST10" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_11.docx" id="ST11" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Deutschman</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Seymour</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Shankar-Hari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Annane</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title>. <source>JAMA</source> (<year>2016</year>) <volume>315</volume>(<issue>8</issue>):<page-range>801&#x2013;10</page-range>. doi: <pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudd</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Agesa</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Shackelford</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Tsoi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kievlan</surname> <given-names>DR</given-names>
</name>
<etal/>
</person-group>. <article-title>Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study</article-title>. <source>Lancet</source> (<year>2020</year>) <volume>395</volume>(<issue>10219</issue>):<page-range>200&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Light</surname> <given-names>B</given-names>
</name>
<name>
<surname>Parrillo</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock</article-title>. <source>Crit Care Med</source> (<year>2006</year>) <volume>34</volume>(<issue>6</issue>):<page-range>1589&#x2013;96</page-range>. doi: <pub-id pub-id-type="doi">10.1097/01.CCM.0000217961.75225.E9</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrer</surname> <given-names>R</given-names>
</name>
<name>
<surname>Martin-Loeches</surname> <given-names>I</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>G</given-names>
</name>
<name>
<surname>Osborn</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Townsend</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dellinger</surname> <given-names>RP</given-names>
</name>
<etal/>
</person-group>. <article-title>Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program</article-title>. <source>Crit Care Med</source> (<year>2014</year>) <volume>42</volume>(<issue>8</issue>):<page-range>1749&#x2013;55</page-range>. doi: <pub-id pub-id-type="doi">10.1097/CCM.0000000000000330</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>. <source>World health assembly 70, resolution 70.7: improving the prevention, diagnosis and clinical management of sepsis</source> (<year>2017</year>). Available at: <uri xlink:href="http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R7-en.pdf">http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R7-en.pdf</uri>.</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Poll</surname> <given-names>T</given-names>
</name>
<name>
<surname>van de Veerdonk</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Scicluna</surname> <given-names>BP</given-names>
</name>
<name>
<surname>Netea</surname> <given-names>MG</given-names>
</name>
</person-group>. <article-title>The immunopathology of sepsis and potential therapeutic targets</article-title>. <source>Nat Rev Immunol</source> (<year>2017</year>) <volume>17</volume>(<issue>7</issue>):<page-range>407&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri.2017.36</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cecconi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>L</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rhodes</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Sepsis and septic shock</article-title>. <source>Lancet</source> (<year>2018</year>) <volume>392</volume>(<issue>10141</issue>):<fpage>75</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(18)30696-2</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scicluna</surname> <given-names>BP</given-names>
</name>
<name>
<surname>van Vught</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Zwinderman</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Wiewel</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Davenport</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Burnham</surname> <given-names>KL</given-names>
</name>
<etal/>
</person-group>. <article-title>Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study</article-title>. <source>Lancet Respir Med</source> (<year>2017</year>) <volume>5</volume>(<issue>10</issue>):<page-range>816&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S2213-2600(17)30294-1</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Diehn</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung cancer</article-title>. <source>JAMA Oncol</source> (<year>2017</year>) <volume>3</volume>(<issue>11</issue>):<page-range>1529&#x2013;37</page-range>. doi: <pub-id pub-id-type="doi">10.1001/jamaoncol.2017.1609</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pages</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mlecnik</surname> <given-names>B</given-names>
</name>
<name>
<surname>Marliot</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bindea</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ou</surname> <given-names>FS</given-names>
</name>
<name>
<surname>Bifulco</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study</article-title>. <source>Lancet</source> (<year>2018</year>) <volume>391</volume>(<issue>10135</issue>):<page-range>2128&#x2013;39</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(18)30789-X</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Phipson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Law</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source> (<year>2015</year>) <volume>43</volume>(<issue>7</issue>):<fpage>e47</fpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eraso-Pichot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Braso-Vives</surname> <given-names>M</given-names>
</name>
<name>
<surname>Golbano</surname> <given-names>A</given-names>
</name>
<name>
<surname>Menacho</surname> <given-names>C</given-names>
</name>
<name>
<surname>Claro</surname> <given-names>E</given-names>
</name>
<name>
<surname>Galea</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>GSEA of mouse and human mitochondriomes reveals fatty acid oxidation in astrocytes</article-title>. <source>Glia</source> (<year>2018</year>) <volume>66</volume>(<issue>8</issue>):<page-range>1724&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.1002/glia.23330</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2005</year>) <volume>102</volume>(<issue>43</issue>):<page-range>15545&#x2013;50</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Green</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Gentles</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>. <source>Nat Methods</source> (<year>2015</year>) <volume>12</volume>(<issue>5</issue>):<page-range>453&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma</article-title>. <source>J Cell Physiol</source> (<year>2020</year>) <volume>235</volume>(<issue>2</issue>):<page-range>1025&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.1002/jcp.29018</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma</article-title>. <source>J Transl Med</source> (<year>2019</year>) <volume>17</volume>(<issue>1</issue>):<fpage>70</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-019-1824-4</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Poll</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shankar-Hari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wiersinga</surname> <given-names>WJ</given-names>
</name>
</person-group>. <article-title>The immunology of sepsis</article-title>. <source>Immunity</source> (<year>2021</year>) <volume>54</volume>(<issue>11</issue>):<page-range>2450&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2021.10.012</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of immune-related genes andimmune infiltration features for early diagnosis, prognosis and recognition of immunosuppression in sepsis</article-title>. <source>Int Immunopharmacol</source> (<year>2022</year>) <volume>107</volume>:<fpage>108650</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2022.108650</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>She</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Predictive value of immune cell counts and neutrophil-to-lymphocyte ratio for 28-day mortality in patients with sepsis caused by intra-abdominal infection</article-title>. <source>Burns Trauma</source> (<year>2021</year>) <volume>9</volume>:<fpage>tkaa040</fpage>. doi: <pub-id pub-id-type="doi">10.1093/burnst/tkaa040</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiersinga</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Leopold</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Cranendonk</surname> <given-names>DR</given-names>
</name>
<name>
<surname>van der Poll</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Host innate immune responses to sepsis</article-title>. <source>Virulence</source> (<year>2014</year>) <volume>5</volume>(<issue>1</issue>):<fpage>36</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.4161/viru.25436</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darden</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Fenner</surname> <given-names>BP</given-names>
</name>
<name>
<surname>Moldawer</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Mohr</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Efron</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Dysregulated immunity and immunotherapy after sepsis</article-title>. <source>J Clin Med</source> (<year>2021</year>) <volume>10</volume>(<issue>8</issue>):<fpage>1742</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm10081742</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor characterization in breast cancer identifies immune-relevant gene signatures associated with prognosis</article-title>. <source>Front Genet</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1119</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fgene.2019.01119</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evrard</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kwok</surname> <given-names>IWH</given-names>
</name>
<name>
<surname>Chong</surname> <given-names>SZ</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>KWW</given-names>
</name>
<name>
<surname>Becht</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>48</volume>(<issue>2</issue>):<fpage>364</fpage>&#x2013;<lpage>379 e368</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2018.02.002</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyme</surname> <given-names>P</given-names>
</name>
<name>
<surname>Thoennissen</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Tseng</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Thoennissen</surname> <given-names>GB</given-names>
</name>
<name>
<surname>Wolf</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Shimada</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>C/EBPepsilon mediates nicotinamide-enhanced clearance of staphylococcus aureus in mice</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>(<issue>9</issue>):<page-range>3316&#x2013;29</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI62070</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>RV</given-names>
</name>
<name>
<surname>Helm</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Schlums</surname> <given-names>H</given-names>
</name>
<name>
<surname>Han</surname> <given-names>H</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>TM</given-names>
</name>
<etal/>
</person-group>. <article-title>The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation</article-title>. <source>Sci Immunol</source> (<year>2021</year>) <volume>6</volume>(<issue>57</issue>)<fpage>:eabc9801</fpage>. doi: <pub-id pub-id-type="doi">10.1126/sciimmunol.abc9801</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Su</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Inducible degradation of lncRNA Sros1 promotes IFN-gamma-mediated activation of innate immune responses by stabilizing Stat1 mRNA</article-title>. <source>Nat Immunol</source> (<year>2019</year>) <volume>20</volume>(<issue>12</issue>):<page-range>1621&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-019-0542-7</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Metabolic reprogramming of macrophages during infections and cancer</article-title>. <source>Cancer Lett</source> (<year>2019</year>) <volume>452</volume>:<fpage>14</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canlet.2019.03.015</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alshalchi</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>GG</given-names>
</name>
</person-group>. <article-title>Involvement of stress-related genes polB and PA14_46880 in biofilm formation of pseudomonas aeruginosa</article-title>. <source>Infect Immun</source> (<year>2014</year>) <volume>82</volume>(<issue>11</issue>):<page-range>4746&#x2013;57</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.01915-14</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guirgis</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Leeuwenburgh</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moldawer</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ghita</surname> <given-names>G</given-names>
</name>
<name>
<surname>Black</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Henson</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis</article-title>. <source>Ann Intensive Care</source> (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>82</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13613-021-00865-x</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almansa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Heredia-Rodriguez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gomez-Sanchez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Andaluz-Ojeda</surname> <given-names>D</given-names>
</name>
<name>
<surname>Iglesias</surname> <given-names>V</given-names>
</name>
<name>
<surname>Rico</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcriptomic correlates of organ failure extent in sepsis</article-title>. <source>J infection</source> (<year>2015</year>) <volume>70</volume>(<issue>5</issue>):<page-range>445&#x2013;56</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2014.12.010</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname> <given-names>VA</given-names>
</name>
<name>
<surname>Joesting</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Freund</surname> <given-names>GG</given-names>
</name>
</person-group>. <article-title>IL-1 receptor 2 (IL-1R2) and its role in immune regulation</article-title>. <source>Brain Behav Immun</source> (<year>2013</year>) <volume>32</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbi.2012.11.006</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Paz</surname> <given-names>P</given-names>
</name>
<name>
<surname>Aragon-Camino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gomez-Sanchez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lorenzo-Lopez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gomez-Pesquera</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fadrique-Fuentes</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression</article-title>. <source>J infection</source> (<year>2021</year>) <volume>83</volume>(<issue>2</issue>):<page-range>147&#x2013;55</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2021.05.039</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Paz</surname> <given-names>P</given-names>
</name>
<name>
<surname>Aragon-Camino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gomez-Sanchez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lorenzo-Lopez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gomez-Pesquera</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lopez-Herrero</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene expression patterns distinguish mortality risk in patients with postsurgical shock</article-title>. <source>J Clin Med</source> (<year>2020</year>) <volume>9</volume>(<issue>5</issue>):<fpage>1276</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm9051276</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-1 receptor 2: A new biomarker for sepsis diagnosis and gram-Negative/Gram-Positive bacterial differentiation</article-title>. <source>Shock</source> (<year>2017</year>) <volume>47</volume>(<issue>1</issue>):<page-range>119&#x2013;24</page-range>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0000000000000714</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antcliffe</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Burnham</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Al-Beidh</surname> <given-names>F</given-names>
</name>
<name>
<surname>Santhakumaran</surname> <given-names>S</given-names>
</name>
<name>
<surname>Brett</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Hinds</surname> <given-names>CJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcriptomic signatures in sepsis and a differential response to steroids. from the VANISH randomized trial</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2019</year>) <volume>199</volume>(<issue>8</issue>):<page-range>980&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1164/rccm.201807-1419OC</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blees</surname> <given-names>A</given-names>
</name>
<name>
<surname>Januliene</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hofmann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Koller</surname> <given-names>N</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>C</given-names>
</name>
<name>
<surname>Trowitzsch</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Structure of the human MHC-I peptide-loading complex</article-title>. <source>Nature</source> (<year>2017</year>) <volume>551</volume>(<issue>7681</issue>):<page-range>525&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature24627</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Anwar</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Achek</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>TLR4/MD2 specific peptides stalled <italic>in vivo</italic> LPS-induced immune exacerbation</article-title>. <source>Biomaterials</source> (<year>2017</year>) <volume>126</volume>:<fpage>49</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.02.023</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Tulzo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pangault</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gacouin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Guilloux</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tribut</surname> <given-names>O</given-names>
</name>
<name>
<surname>Amiot</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome</article-title>. <source>Shock</source> (<year>2002</year>) <volume>18</volume>(<issue>6</issue>):<page-range>487&#x2013;94</page-range>. doi: <pub-id pub-id-type="doi">10.1097/00024382-200212000-00001</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>HP</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>BY</given-names>
</name>
<name>
<surname>Chuang</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YC</given-names>
</name>
</person-group>. <article-title>Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis</article-title>. <source>Inflammation Res</source> (<year>2013</year>) <volume>62</volume>(<issue>8</issue>):<page-range>751&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00011-013-0630-3</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>F</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>A shift toward inhibitory receptors and impaired effector functions on NK cells contribute to immunosuppression during sepsis</article-title>. <source>J Leukoc Biol</source> (<year>2020</year>) <volume>107</volume>(<issue>1</issue>):<fpage>57</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1002/JLB.4A0818-313RR</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza-Fonseca-Guimaraes</surname> <given-names>F</given-names>
</name>
<name>
<surname>Parlato</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fitting</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cavaillon</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Adib-Conquy</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>(<issue>12</issue>):<page-range>5850&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1103616</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essandoh</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>GC</given-names>
</name>
</person-group>. <article-title>MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response</article-title>. <source>Shock</source> (<year>2016</year>) <volume>46</volume>(<issue>2</issue>):<page-range>122&#x2013;31</page-range>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0000000000000604</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rackov</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hernandez-Jimenez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Shokri</surname> <given-names>R</given-names>
</name>
<name>
<surname>Carmona-Rodriguez</surname> <given-names>L</given-names>
</name>
<name>
<surname>Manes</surname> <given-names>S</given-names>
</name>
<name>
<surname>Alvarez-Mon</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>p21 mediates macrophage reprogramming through regulation of p50-p50 NF-kappaB and IFN-beta</article-title>. <source>J Clin Invest</source> (<year>2016</year>) <volume>126</volume>(<issue>8</issue>):<page-range>3089&#x2013;103</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI83404</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>
